Localization of PPARδ in murine central nervous system:: expression in oligodendrocytes and neurons

被引:104
作者
Woods, JW
Tanen, M
Figueroa, DJ
Biswas, C
Zycband, E
Moller, DE
Austin, CP
Berger, JP
机构
[1] Merck & Co Inc, Merck Sharp & Dohme Res Labs, Dept Inflammat Res, Rahway, NJ 07065 USA
[2] Dept Metab Dis, Rahway, NJ 07065 USA
[3] Merck Res Labs, Dept Neurosci, W Point, PA 19486 USA
关键词
peroxisome proliferator-activated receptors; CNS; brain; immunolocalization;
D O I
10.1016/S0006-8993(03)02515-0
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The peroxisome proliferator-activated receptors (PPARs), PPARdelta, PPARgamma and PPARalpha, comprise a subclass of the supergene family of nuclear receptors. As such they are ligand-regulated transcription factors whose major effects are mediated by altering expression of target genes. PPARdelta has been shown to be ubiquitously expressed in mammals. However, its primary biological role(s) has yet to be defined. Several recent studies have demonstrated that PPARdelta is the most highly expressed PPAR isoform. in the central nervous system, but ambiguity still exists as to the specific brain sub-regions and cells in which it is expressed. Here, utilizing novel, isoform-selective PPARdelta riboprobes and an anti-peptide antibody, we performed a series of in situ hybridization and immunolocalization studies to determine the distribution of PPARdelta in the central nervous system (CNS) of mice. We found that PPARdelta mRNA and protein is expressed throughout the brain, with particularly high levels in the entorhinal cortex, hypothalamus and hippocampus, and lower levels in the corpus callosum and caudate putamen. At the cellular level, PPARdelta mRNA and protein were found to be expressed in oligodendrocytes and neurons but not astrocytes. Such results suggest a role for PPARdelta in both myelination land neuronal functioning within the CNS. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:10 / 21
页数:12
相关论文
共 31 条
[1]   Effects of peroxisome proliferator-activated receptor δ on placentation, adiposity, and colorectal cancer [J].
Barak, Y ;
Liao, D ;
He, WM ;
Ong, ES ;
Nelson, MC ;
Olefsky, JM ;
Boland, R ;
Evans, RM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (01) :303-308
[2]   The mechanisms of action of PPARs [J].
Berger, J ;
Moller, DE .
ANNUAL REVIEW OF MEDICINE, 2002, 53 :409-435
[3]   A PPARγ mutant serves as a dominant negative inhibitor of PPAR signaling and is localized in the nucleus [J].
Berger, J ;
Patel, HV ;
Woods, J ;
Hayes, NS ;
Parent, SA ;
Clemas, J ;
Leibowitz, MD ;
Elbrecht, A ;
Rachubinski, RA ;
Capone, JP ;
Moller, DE .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2000, 162 (1-2) :57-67
[4]  
BERGER T, 2000, J NEURAL TRANSM-SUPP, V1, P351
[5]  
Bocher V, 2002, ANN NY ACAD SCI, V967, P7
[6]   Differential expression of peroxisome proliferator-activated receptor-α, -β, and -γ during rat embryonic development [J].
Braissant, O ;
Wahli, W .
ENDOCRINOLOGY, 1998, 139 (06) :2748-2754
[7]   Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat [J].
Braissant, O ;
Foufelle, F ;
Scotto, C ;
Dauca, M ;
Wahli, W .
ENDOCRINOLOGY, 1996, 137 (01) :354-366
[8]   The corticostriatal projection: From synaptic plasticity to dysfunctions of the basal ganglia [J].
Calabresi, P ;
Pisani, A ;
Mercuri, NB ;
Bernardi, G .
TRENDS IN NEUROSCIENCES, 1996, 19 (01) :19-24
[9]  
Cullingford TE, 1998, J NEUROCHEM, V70, P1366
[10]   Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2 [J].
Elbrecht, A ;
Chen, YL ;
Cullinan, CA ;
Hayes, N ;
Leibowitz, MD ;
Moller, DE ;
Berger, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 224 (02) :431-437